H-index: RSCI 12, Scopus 3, Web of Science 3
About the Department
The department was established in 1980. The team comprises 45 members including five doctors of medical sciences, two professors, three candidates of medical sciences, and four high level certificate physicians. Employees of the department defended nine dissertations for degree of doctor of medical sciences and 33 dissertations for degree of candidate of medical sciences; they published over 1000 scientific works including 27 books, 10 chapters in the books, 483 articles in
Main areas of scientific research
The study of specifics in pathogenesis, clinical course, drug correction, and prognosis of coronary atherosclerosis and various variants of cardiomyopathies; development and analysis of the register of pulmonary artery thromboembolism; development and implementation of new
Pathogenetic specifics of cardiac biomechanics, coronary hemodynamics, and regulation of arterial blood pressure in the context of structural changes in the myocardium and coronary arteries in patients with dilated and hypertrophic cardiomyopathies as well as left ventricular hypertrophy have been studied.
Pathogenetic, clinical, instrumental, and pharmacological peculiarities in coronary and peripheral atherosclerotic damage associated with dyslipidemias, metabolic syndrome, diabetes mellitus, and arterial hypertension were studied.
New technologies of
The ways for optimization of diagnostics and
The department is equipped with two ultrasonic apparatuses Vivid Е9 (GEHealthcare, USA) and HDI 5000 SonoCT (Philips, Germany), system for
The methods for the assessments of cardiac deformation, rotation, and twist, 3D reconstruction of the mitral and aortic valves, transthoracic ultrasound diagnosis of stenosis and occlusion of the coronary arteries, coronary reserve, as well as the extracorporeal methods for correction of the abnormal lipid metabolism are widely implemented in the clinic.
The approaches to optimization of therapy for coronary insufficiency and heart failure including comorbidities with hypertension and carbohydrate metabolism abnormalities as well as the criteria for prediction of the progression and outcomes of pulmonary embolism are implemented in daily routine. Annually, over 1000 patients receive highly specialized medical help in the department.